Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Docetaxel and ADT Before Prostatectomy
NCT00430183Phase 3Active, not recruiting
- Sponsor
- Cancer and Leukemia Group B
- Start
- May 2007
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of docetaxel in prostate cancer (PCa), sponsored by Cancer and Leukemia Group B. Started May 2007; status: active, not recruiting.
02
Drugs
docetaxel
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00430183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00430183.